GovBidPulseFormDPulseAccessPulseCitePulseLocalSchemaPulseIntelligence feedsSupport

28bio, Inc. raised $8,524,945 (Metairie, LA)

LIVE PUBLIC DATA Source: SEC EDGAR Form D filings (U.S. Securities and Exchange Commission) · Last refreshed: Wed, 04 Nov 2026 01:28:40 GMT

28bio, Inc. plus every comparable record, with all columns and source links, as one CSV.

Not investment advice and not an offer or solicitation to buy or sell any security.

70 / 100 vendor spend propensity

Estimated post-raise budget for CPA / Tax / Audit services: $170,499 (heuristic)

  • Operating company: new capital typically funds hiring, facilities and vendors.
  • Raised $8,524,945 so far.
  • Healthcare & Life Sciences companies are a strong fit for CPA / Tax / Audit services.
  • Filed 6 days ago.
FieldValue
IndustryBiotechnology (Healthcare & Life Sciences)
Operating companyYes
Exemption506(b)
Amount sold$8,524,945
Total offering$8,524,945
Investors so far10
First sale2025-05-21
Filed2026-10-29 (amendment)
EntityCorporation

Executives and related persons (from the filing)

  • Alif Saleh: Executive Officer, Director
  • David Weiner: Director
  • Dale Pfost: Director
  • Michael Katz: Director
  • Miklos Kobor: Director
  • Paul Friel: Director

View the filing on SEC EDGAR

Markdown version

28bio, Inc. vs. top 3 peers

OrganizationLocationCapital raisedRecord date
28bio, Inc.Metairie$8,524,9452026-10-29
Trellis Bioscience, Inc.Redwood City$9,093,0002026-10-29
Septal Solutions, Inc.Exton$7,319,6952026-10-27
SymKardia, Inc.Westlake$4,000,0002026-10-28

Related records

Newly funded companies in Louisiana (SEC Form D) Newly funded Healthcare & Life Sciences companies (SEC Form D)

Get new raises like this every morning

FormDPulse emails you newly funded companies that match your ideal customer profile.

See plans

Often used together

Or get the Advisor Prospecting Bundle for $14.99 one-time: Full CSV unlock of newly funded companies plus a grant readiness pack.